Paediatric

Impetigo

Advise people with impetigo, and their parents or carers if appropriate, to seek medical help if symptoms worsen rapidly or significantly at any time, or have not improved after completing a course of treatment. 

Reassess people with impetigo if their symptoms worsen rapidly or significantly at any time or have not improved after completing a course of treatment.

When reassessing people with impetigo, take account of:

  • other possible diagnoses, such as herpes simplex.
  • any symptoms or signs suggesting a more serious illness or condition, such as cellulitis. 
  • previous antibiotic use, which may have led to resistant bacteria.

Advise people with impetigo, and their parents or carers if appropriate, about good hygiene measures to reduce the spread of impetigo to other areas of the body and to other people.

Localised non-bullous impetigo

Preferred

Fusidic acid 2% cream, apply TDS for 5 days

 

Alternative

If fusidic acid resistance suspected or confirmed:  Mupirocin 2% cream Apply TDS for 5 days

If Impetigo is worsening or has not improved after completing a course of topical antibiotics:

  • Offer a short course of oral antibiotics (see section below) AND 
  • Consider sending a skin swab for microbiological testing. Review treatment when sensitivities are available.

Widespread non-bullous impetigo OR bullous impetigo OR systemically unwell or at high risk of complications

Note: If impetigo is worsening or has not improved after completing a course of oral antibiotics consider sending a skin swab for microbiological testing.

Preferred

flucloxacillin po 

Age flucloxacillin  oral dose
1 month to 1 year 62.5 mg to 125 mg QDS for 5 days
2 to 9 years 125 mg to 250 mg QDS for 5 days
10 to 17 years 250 mg to 500 mg QDS for 5 days

If flucloxacillin po not tolerated (ie. suspension unpalatable) alternative is: cefalexin 25 mg/kg (max 1g) po TDS

Alternative

For penicillin allergy (severe and non-severe)

clarithromycin po, see dosing table, for 5 days

Weight clarithromycin oral dose
under 8 kg 7.5 mg/kg BD
8 to 11 kg 62.5 mg BD
12 to 19 kg 125 mg BD
20 to 29 kg 187.5 mg BD
30 to 40 kg 250 mg BD
12 to 17 years 500 mg BD

In pregnancy: erythromycin 250 mg to 500 mg QDS for 5 days

 

Recurrent impetigo

Send a skin swab for microbiological testing and;

  • Consider taking a nasal swab and starting treatment for MRSA decolonisation
  • Review treatment when sensitivities are available.

Editorial Information

Last reviewed: 01 Jul 2020

Author(s): AMST.

Approved By: MMTC